QCI Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

QCI Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-31	Closed	-$2K	–	559
2016 Q2	$2K	Buy	+31	New	+$1.65K	﹤0.01%	505
2015 Q1	–	Sell	-70	Closed	-$4K	–	528
2014 Q4	$4K	Hold	70	–	–	﹤0.01%	448
2014 Q3	$4K	Hold	70	–	–	﹤0.01%	448
2014 Q2	$4K	Hold	70	–	–	﹤0.01%	438
2014 Q1	$4K	Hold	70	–	–	﹤0.01%	439
2013 Q4	$3K	Sell	70 -202,330	-100%	-$7.97M	﹤0.01%	462
2013 Q3	$7.65M	Buy	202,400 +6,344	+3%	+$247K	1.38%	43
2013 Q2	$7.68M	Buy	+196,056	New	+$7.64M	1.45%	42

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

QCI Asset Management's TEVA Position: Q3 2016 in Review

QCI Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2016, closing a stake of 31 shares — an estimated $2K sold.

QCI Asset Management first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $7.68M in Q2 2013. 798 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

QCI Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2016 after selling out during the quarter.
QCI Asset Management sold 31 Teva Pharmaceutical Industries Limited shares in Q3 2016, an estimated $2K.
QCI Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 8 quarters.
QCI Asset Management's Teva Pharmaceutical Industries Limited position peaked at $7.68M in Q2 2013.
798 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2016.

Based on QCI Asset Management's 13F filing for Q3 2016, filed 4 Nov 2016.